98 related articles for article (PubMed ID: 22576797)
1. Downregulation of hepatoma-derived growth factor suppresses the malignant phenotype of U87 human glioma cells.
Zhang A; Long W; Guo Z; Guo Z; Cao BB
Oncol Rep; 2012 Jul; 28(1):62-8. PubMed ID: 22576797
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
3. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
Guerin C; Luddy C; Abounader R; Lal B; Laterra J
Biochem Biophys Res Commun; 2000 Jun; 273(1):287-93. PubMed ID: 10873600
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
[TBL] [Abstract][Full Text] [Related]
5. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
7. Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells.
Guo Z; He Y; Wang S; Zhang A; Zhao P; Gao C; Cao B
Oncol Rep; 2011 Aug; 26(2):511-7. PubMed ID: 21567096
[TBL] [Abstract][Full Text] [Related]
8. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
9. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
[TBL] [Abstract][Full Text] [Related]
10. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
[TBL] [Abstract][Full Text] [Related]
11. p53 negatively regulates the hepatoma growth factor HDGF.
Sasaki Y; Negishi H; Idogawa M; Yokota I; Koyama R; Kusano M; Suzuki H; Fujita M; Maruyama R; Toyota M; Saito T; Tokino T
Cancer Res; 2011 Nov; 71(22):7038-47. PubMed ID: 22006999
[TBL] [Abstract][Full Text] [Related]
12. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).
Lepourcelet M; Tou L; Cai L; Sawada J; Lazar AJ; Glickman JN; Williamson JA; Everett AD; Redston M; Fox EA; Nakatani Y; Shivdasani RA
Development; 2005 Jan; 132(2):415-27. PubMed ID: 15604097
[TBL] [Abstract][Full Text] [Related]
13. The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.
Zhou Y; Zhang J; Liu Q; Bell R; Muruve DA; Forsyth P; Arcellana-Panlilio M; Robbins S; Yong VW
Carcinogenesis; 2005 Dec; 26(12):2058-68. PubMed ID: 16033775
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the expression of HDGF attenuates malignant biological behaviors of hilar cholangiocarcinoma cells.
Liu Y; Sun J; Yang G; Liu Z; Guo S; Zhao R; Xu K; Wu X; Zhang Z
Mol Med Rep; 2015 Sep; 12(3):4713-4719. PubMed ID: 26081074
[TBL] [Abstract][Full Text] [Related]
15. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
16. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
17. Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells.
Lin WL; Liang WH; Lee YJ; Chuang SK; Tseng TH
Chem Biol Interact; 2010 Dec; 188(3):607-15. PubMed ID: 20836997
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma-derived growth factor promotes the resistance to anti-tumor effects of nordihydroguaiaretic acid in colorectal cancer cells.
Liao F; Liu M; Lv L; Dong W
Eur J Pharmacol; 2010 Oct; 645(1-3):55-62. PubMed ID: 20674562
[TBL] [Abstract][Full Text] [Related]
20. Human malignant glioma cells expressing functional formylpeptide receptor recruit endothelial progenitor cells for neovascularization.
Xu CP; Zhang HR; Chen FL; Yao XH; Liang ZQ; Zhang R; Cui Y; Qian C; Bian XW
Int Immunopharmacol; 2010 Dec; 10(12):1602-7. PubMed ID: 20933627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]